InsidersTradesSigma
Follow the 네이처셀 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 네이처셀 has recorded 1 public disclosures. Market capitalisation: €1,607.7bn. The latest transaction was reported on 20 March 2026 (Purchase). Among the most active insiders: 라정찬. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
네이처셀 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de terapias celulares y productos biofarmacéuticos.